We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), which is a rare progressive condition that runs in families caused by a protein called transthyretin (TTR).
Information on nerve agents, for use in responding to chemical incidents.
Find out more about Dstl's central role in the response to the nerve agent attack in 2018—one of the most serious criminal and international incidents in recent years.
Deaths Registered in Northern Ireland - Week ending 17th July 2020
Deaths Registered in Northern Ireland - Week ending 23 June 2023
Deaths Registered in Northern Ireland - Week ending 31st July 2020
Projects granted during 2015 with a primary purpose of basic research: nervous system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).